SciDev.net [24 April, 2017]
“Tackle NTDs with innovation, but not just from science”
Reuters [21 April, 2017]
“Progress in fighting tropical diseases but funding and conflicts pose challenges”
Radio Okapi [20 April, 2017]
“RDC: des efforts sont nécessaires pour éliminer les maladies tropicales négligées” – “DRC: efforts needed to eliminate neglected tropical diseases”
Yomiuri Online [20 April, 2017]
“DNDiの「創薬ブースター」コンソーシアムに、メルク社(ドイツ)が新たに参加 －顧みられない病気の創薬を加速する” – “Merck AG (Germany) newly participates in DNDi‘s “Drug Discovery Booster” consortium”
Devex [20 April, 2017]
“Commitments made on neglected tropical diseases at WHO summit”
PLOS NTDs [20 April, 2017]
“Neglected tropical diseases: A DFID perspective”
by Thompson AM, Blaser A, Palmer BD, Anderson RF, Shinde SS, Launay D, Chatelain E, Maes L, Franzblau SG, Wan B, Wang Y, Ma Z, Denny WA.
Bioorganic and Medicinal Chemistry Letters, March 2017
Scroll.in [19 April, 2017]
“A small group of researchers are making big strides in combating kala azar”
Le Temps [19 April, 2017]
“Des progrès dans la lutte contre les maladies tropicales négligées” – “Progress in addressing neglected tropical diseases”
Le Monde [19 April, 2017]
“Mobilisation contre les maladies tropicales négligées” – “Mobilization against neglected tropical diseases”
PLOS Blog [19 April, 2017]
“Combatting neglected tropical diseases: much progress, but millions of neglected patients lack access to care”
Devex [18 April, 2017]
“Strides in progress on Neglected Tropical Diseases as global partners meet”
[Geneva, Switzerland – 19 April 2017]
The pharmaceutical company Merck has become the sixth company to join the “Neglected Tropical Diseases Drug Discovery Booster” consortium, a new initiative to accelerate and cut the cost of early-stage drug discovery for two of the world’s most neglected diseases, leishmaniasis and Chagas disease.
10th European Congress on Tropical Medicine and International Health
October 16-20, 2017
DNDi will be participating at the event.
Financial Times [18 April, 2017]
“The long road to elimination of neglected tropical diseases”
DNDi is very pleased to announce the renewed commitment of the Global Health Innovative Technology Fund (GHIT), its donor since 2013, to DNDi projects on leishmaniasis and Chagas disease.
[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.